Tribio Anti-BCMA & BCMA & CD3 Bispecific Antibody (TBS10497)
$369.00 – $1,479.00
| SKU | Stock | SIZE (mg) | Price | Quantity | ||
|---|---|---|---|---|---|---|
| TBS10497-100 | Yes | 100 UG | $369.00 | |||
| TBS10497-1 | Yes | 1 MG | $1,479.00 |
- Description
- Terms
- Additional information
- Reviews (0)
Description
Description: Trbio Anti-BCMA & BCMA & CD3 Bispecific Antibody is designed to target BCMA on plasma cells and CD3 on T cells, redirecting T cells to kill BCMA-expressing malignant cells. It is mainly used in multiple myeloma research and preclinical immunotherapy studies to evaluate T-cell–engaging strategies against B-cell lineage tumors.
Applications: ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Species reactivity: Human
Host species: Human
Target: Tumor necrosis factor receptor superfamily member 17, B-cell maturation protein, CD269, TNFRSF17, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E
Isotype: Half IgG+ScFv
Accession/UniProt: Q02223 & P07766
Concentration: 3 mg/ml
Purity: >95%
Formulation: Liquid
Storage buffer: 0.01M PBS, pH 7.4
Purification: Protein A/G purified from cell culture supernatant.
Clonality: Monoclonal
Storage: Avoid repeated freeze-thaw cycles. -20°C for 12 months; -80°C for long-term storage.
Research use only.
Additional information
| SIZE (mg) | 1 MG, 100 UG |
|---|
Be the first to review “Tribio Anti-BCMA & BCMA & CD3 Bispecific Antibody (TBS10497)”
You must be logged in to post a review.
Reviews
There are no reviews yet.